Hannes Hagström

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Adjungerad professor och biträdande överläkare inom hepatologi. Mer information finns på KI:s engelska sida (https://ki.se/en/people/hahags).
Jag tog min doktorsexamen från Karolinska Institutet 2007 och är specialist inom hepatologi. Jag försvarade min avhandling 2016 och är docent i
hepatologi sedan 2019, med en adjungerad professur sedan 2024. Jag leder en forskargrupp vid avdelningen för gastroenterologi och
reumatologi [1] vid Institutionen för Medicin i Huddinge. Nuvarande projekt fokuserar på epidemiologin vid MASLD där vår grupp har varit med och
skapat några av de globalt största kohorterna och vi har ett brett internationellt nätverk. Jag har flertal uppdrag inom Svensk gastroenterologi, och har bland annat ansvarat för att ta fram svenska riktlinjer för MASLD. Mer information om min forskning finns på den engelska sidan Hannes Hagström group [2]
[1] https://ki.se/medh/hannes-hagstroms-forskargrupp-fettleversjukdom-i-fokus-ur-ett-kliniskt-och-epidemiologiskt
[2] https://ki.se/en/medh/hagstrom-group

Artiklar

Article: LIVER INTERNATIONAL. 2024;44(7):1689-1699

Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients.

Hegmar H; Wester A; Aleman S; Backman J; Degerman E; Ekvall H; Lund K; Lundgren Å; Nasr P; Shahnavaz A; Vessby J; Westin J; Önnerhag K; Hagström H
Article: DIABETES CARE. 2024;47(6):978-985

Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes.

Shang Y; Grip ET; Modica A; Skröder H; Ström O; Ntanios F; Gudbjörnsdottir S; Hagström H
Journal article: HEPATOLOGY COMMUNICATIONS. 2024;8(6):e0423

Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis.

Younossi ZM; Mangla KK; Berentzen TL; Grau K; Kjær MS; Ladelund S; Nitze LM; Coolbaugh C; Hsu C-Y; Hagström H
Journal article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;:S1542-3565(24)00409-9

Reply.

Nasr P; Hagström H
Article: LIVER INTERNATIONAL. 2024;44(5):1253-1264

Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD.

Yang W; Ebrahimi F; Romeo S; Holmer M; Vessby J; Ekstedt M; Ludvigsson JF; Shang Y; Hagström H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(5):1048-1057.e2

Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis.

Nasr P; Wester A; Ekstedt M; Strandberg R; Kechagias S; Shang Y; Widman L; Hagström H
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024;59(9):1111-1121

Prevalence and risk factors of metabolic dysfunction-associated steatotic liver disease in south Central Uganda: A cross-sectional survey.

Enriquez R; Homsi M; Ssekubugu R; Nabukalu D; Zeebari Z; Marrone G; Gigante B; Chang LW; Reynolds SJ; Nalugoda F; Ekström AM; Hagström H; Nordenstedt H
Article: LIVER INTERNATIONAL. 2024

Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based study.

Wester A; Jepsen P; Hagström H
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2024;331(15):1287-1297

Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.

Lin H; Lee HW; Yip TC-F; Tsochatzis E; Petta S; Bugianesi E; Yoneda M; Zheng M-H; Hagström H; Boursier J; Calleja JL; Goh GB-B; Chan W-K; Gallego-Durán R; Sanyal AJ; de Lédinghen V; Newsome PN; Fan J-G; Castéra L; Lai M; Harrison SA; Fournier-Poizat C; Wong GL-H; Pennisi G; Armandi A; Nakajima A; Liu W-Y; Shang Y; de Saint-Loup M; Llop E; Teh KK-J; Lara-Romero C; Asgharpour A; Mahgoub S; Chan MS-W; Canivet CM; Romero-Gomez M; Kim SU; Wong VW-S; VCTE-Prognosis Study Group
Article: GUT. 2024;73(5):825-834

Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.

Armandi A; Sanavia T; Younes R; Caviglia GP; Rosso C; Govaere O; Liguori A; Francione P; Gallego-Duràn R; Ampuero J; Pennisi G; Aller R; Tiniakos D; Burt A; David E; Vecchio F; Maggioni M; Cabibi D; McLeod D; Pareja MJ; Zaki MYW; Grieco A; Stål P; Kechagias S; Fracanzani AL; Valenti L; Miele L; Fariselli P; Eslam M; Petta S; Hagström H; George J; Schattenberg JM; Romero-Gómez M; Anstee QM; Bugianesi E
Article: GUT. 2024;73(5):835-843

Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes.

Wester A; Shang Y; Toresson Grip E; Matthews AA; Hagström H
Article: LIVER INTERNATIONAL. 2024;44(8):1872-1885

Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis.

Mózes FE; Lee JA; Vali Y; Selvaraj EA; Jayaswal ANA; Boursier J; de Lédinghen V; Lupșor-Platon M; Yilmaz Y; Chan W-K; Mahadeva S; Karlas T; Wiegand J; Shalimar; Tsochatzis E; Liguori A; Wong VW-S; Lee DH; Holleboom AG; van Dijk A-M; Mak AL; Hagström H; Akbari C; Hirooka M; Lee DH; Kim W; Okanoue T; Shima T; Nakajima A; Yoneda M; Thuluvath PJ; Li F; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Fournier-Poizat C; Geier A; Tuthill T; Yunis C; Anstee QM; Harrison SA; Bossuyt PM; Pavlides M
Article: ADDICTION. 2024;119(4):706-716

Disentangling the contributions of alcohol use disorder and alcohol-related liver disease towards dementia: A population-based cohort study.

Zhao S; Widman L; Hagström H; Shang Y
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(4):749-759.e19

Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease.

Sharma R; Simon TG; Hagström H; Lochhead P; Roelstraete B; Söderling J; Verna EC; Emond J; Ludvigsson JF
Article: MOLECULAR SYSTEMS BIOLOGY. 2024;20(4):374-402

Estrogen receptor activation remodels TEAD1 gene expression to alleviate hepatic steatosis.

Sommerauer C; Gallardo-Dodd CJ; Savva C; Hases L; Birgersson M; Indukuri R; Shen JX; Carravilla P; Geng K; Nørskov Søndergaard J; Ferrer-Aumatell C; Mercier G; Sezgin E; Korach-André M; Petersson C; Hagström H; Lauschke VM; Archer A; Williams C; Kutter C
Article: JHEP REPORTS. 2024;6(2):100915

Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD.

Akbari C; Dodd M; Stål P; Nasr P; Ekstedt M; Kechagias S; Vessby J; Rorsman F; Zhang X; Wang T; Jemielita T; Fernandes G; Engel SS; Hagström H; Shang Y
Article: HEPATOLOGY COMMUNICATIONS. 2024;8(2):e0386

The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement.

Hagström H; Adams LA; Allen AM; Byrne CD; Chang Y; Duseja A; Grønbæk H; Ismail MH; Jepsen P; Kanwal F; Kramer J; Loomba R; Mark HE; Newsome PN; Rinella ME; Rowe IA; Ryu S; Sanyal A; Schattenberg JM; Serper M; Sheron N; Simon TG; Spearman CW; Tapper EB; Villota-Rivas M; Wild SH; Wong VW-S; Yilmaz Y; Zelber-Sagi S; Åberg F; Lazarus JV
Article: HEPATOLOGY. 2024;79(2):502-523

A global action agenda for turning the tide on fatty liver disease.

Lazarus JV; Mark HE; Allen AM; Arab JP; Carrieri P; Noureddin M; Alazawi W; Alkhouri N; Alqahtani SA; Anstee QM; Arrese M; Bataller R; Berg T; Brennan PN; Burra P; Castro-Narro GE; Cortez-Pinto H; Cusi K; Dedes N; Duseja A; Francque SM; Gastaldelli A; Hagström H; Huang TTK; Ivancovsky Wajcman D; Kautz A; Kopka CJ; Krag A; Newsome PN; Rinella ME; Romero D; Sarin SK; Silva M; Spearman CW; Terrault NA; Tsochatzis EA; Valenti L; Villota-Rivas M; Zelber-Sagi S; Schattenberg JM; Wong VW-S; Younossi ZM; on behalf of the
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2024;9(1):83-91

Implementation of a liver health check in people with type 2 diabetes.

Abeysekera KWM; Valenti L; Younossi Z; Dillon JF; Allen AM; Nourredin M; Rinella ME; Tacke F; Francque S; Ginès P; Thiele M; Newsome PN; Guha IN; Eslam M; Schattenberg JM; Alqahtani SA; Arrese M; Berzigotti A; Holleboom AG; Caussy C; Cusi K; Roden M; Hagström H; Wong VW-S; Mallet V; Castera L; Lazarus JV; Tsochatzis EA
Article: PLOS ONE. 2024;19(5):e0294695

Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis.

Bengtsson B; Maucourant C; Sandberg JK; Björkström NK; Hagström H
Article: CARDIOVASCULAR DIABETOLOGY. 2023;22(1):343

Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study.

Simon TG; Ebrahimi F; Roelstraete B; Hagström H; Sundström J; Ludvigsson JF
Article: JOURNAL OF HEPATOLOGY. 2023;79(6):1366-1373

Progression of non-alcoholic fatty liver disease and long-term outcomes: A nationwide paired liver biopsy cohort study.

Simon TG; Roelstraete B; Hagström H; Loomba R; Ludvigsson JF
Article: JOURNAL OF HEPATOLOGY. 2023;79(6):1374-1384

Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study.

Ebrahimi F; Hagström H; Sun J; Bergman D; Shang Y; Yang W; Roelstraete B; Ludvigsson JF
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(13):3346-3355.e19

Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study.

Ebrahimi F; Simon TG; Hagström H; Söderling J; Wester A; Roelstraete B; Ludvigsson JF
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(13):3336-3345.e2

Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients.

Hagström H; Shang Y; Tapper EB; Wester A; Widman L
Journal article: EUROPEAN HEART JOURNAL. 2023;44:ehad655.2647

The incidence of coronary artery disease in all Swedish liver transplant patients between 1987 and 2020: A national prospective study

Lewinter C; Widman L; Hagstrom H
Journal article: EUROPEAN HEART JOURNAL. 2023;44:ehad655.2648

The incidence of coronary artery disease after liver transplant: a meta-analysis

Tabulo Z; Hagstrom H; Braunschweig F; Lewinter C
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2023;11(9):852-860

Four-fold increased mortality rate in patients with Wilson's disease: A population-based cohort study of 151 patients.

Åberg F; Shang Y; Strandberg R; Wester A; Widman L; Hagström H
Journal article: CANADIAN JOURNAL OF DIABETES. 2023;47(7):s200-s201

THE RELATIONSHIP BETWEEN LIVER HISTOLOGY AND LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A REAL-WORLD COHORT STUDY

McLeod M; Younossi Z; Mangla K; Berentzen T; Grau K; Kjaer M; Ladelund S; Nitze L; Coolbaugh C; Hsu C; Hagström H
Article: HEPATOLOGY COMMUNICATIONS. 2023;7(11):e0238

Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study.

Shang Y; Shen Q; Tapper EB; Wester A; Hagström H
Article: LIVER INTERNATIONAL. 2023;43(10):2186-2197

Antibiotic use and development of nonalcoholic fatty liver disease: A population-based case-control study.

Ebrahimi F; Simon TG; Hagström H; Sun J; Bergman D; Forss A; Roelstraete B; Engstrand L; Ludvigsson JF
Article: LIVER INTERNATIONAL. 2023;43(10):2142-2152

Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort study.

Shang Y; Widman L; Ebrahimi F; Ludvigsson JF; Hagström H; Wester A
Journal article: CANADIAN JOURNAL OF CARDIOLOGY. 2023;39(10):s241

THE RELATIONSHIP BETWEEN LIVER HISTOLOGY AND LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A REAL-WORLD COHORT STUDY

McLeod M; Younossi Z; Mangla K; Berentzen T; Grau K; Kjaer M; Ladelund S; Nitze L; Coolbaugh C; Hsu C; Hagström H
Article: HEPATOLOGY COMMUNICATIONS. 2023;7(10):e0279

Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study.

Wester A; Shang Y; Stål P; Hagström H
Article: JOURNAL OF HEPATOLOGY. 2023;79(3):618-634

A global research priority agenda to advance public health responses to fatty liver disease.

Lazarus JV; Mark HE; Allen AM; Arab JP; Carrieri P; Noureddin M; Alazawi W; Alkhouri N; Alqahtani SA; Arrese M; Bataller R; Berg T; Brennan PN; Burra P; Castro-Narro GE; Cortez-Pinto H; Cusi K; Dedes N; Duseja A; Francque SM; Hagström H; Huang TT-K; Wajcman DI; Kautz A; Kopka CJ; Krag A; Miller V; Newsome PN; Rinella ME; Romero D; Sarin SK; Silva M; Spearman CW; Tsochatzis EA; Valenti L; Villota-Rivas M; Zelber-Sagi S; Schattenberg JM; Wong VW-S; Younossi ZM; Healthy Livers, Healthy Lives Collaborators
Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2023;38(9):973-984

Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019.

Nasr P; von Seth E; Mayerhofer R; Ndegwa N; Ludvigsson JF; Hagström H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2023;58(8):931-936

Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients.

Åström H; Wester A; Hagström H
Article: JOURNAL OF INTERNAL MEDICINE. 2023;294(2):164-177

Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population-based cohort study.

Schönau J; Wester A; Schattenberg JM; Hagström H
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2023;8(8):704-713

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.

Mózes FE; Lee JA; Vali Y; Alzoubi O; Staufer K; Trauner M; Paternostro R; Stauber RE; Holleboom AG; van Dijk A-M; Mak AL; Boursier J; de Saint Loup M; Shima T; Bugianesi E; Gaia S; Armandi A; Shalimar; Lupșor-Platon M; Wong VW-S; Li G; Wong GL-H; Cobbold J; Karlas T; Wiegand J; Sebastiani G; Tsochatzis E; Liguori A; Yoneda M; Nakajima A; Hagström H; Akbari C; Hirooka M; Chan W-K; Mahadeva S; Rajaram R; Zheng M-H; George J; Eslam M; Petta S; Pennisi G; Viganò M; Ridolfo S; Aithal GP; Palaniyappan N; Lee DH; Ekstedt M; Nasr P; Cassinotto C; de Lédinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Fournier-Poizat C; Geier A; Martic M; Tuthill T; Anstee QM; Harrison SA; Bossuyt PM; Pavlides M; LITMUS investigators
Article: JOURNAL OF INTERNAL MEDICINE. 2023;294(2):216-227

Increased risk for microvascular outcomes in NAFLD-A nationwide, population-based cohort study.

Ebert T; Widman L; Stenvinkel P; Hagström H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(7):1841-1853.e12

Cardiovascular Outcomes in Patients With Biopsy-proven Alcohol-related Liver Disease.

Hagström H; Thiele M; Sharma R; Simon TG; Roelstraete B; Söderling J; Sundström J; Ludvigsson JF
Article: NUTRITION. 2023;110:111982

Macronutrient composition and its effect on body composition changes during weight loss therapy in patients with non-alcoholic fatty liver disease: Secondary analysis of a randomized controlled trial.

Lindqvist C; Holmer M; Hagström H; Petersson S; Tillander V; Brismar TB; Stål P
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s857

SAT-115 Healthcare resource use and costs among patients with primary sclerosing cholangitis in Sweden-a retrospective population-based cohort study

Bergquist A; Kachru N; Aldvén M; Ström O; Knutsson D; Grip ET; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s654

SAT-399 Prevalence of NAFLD and advanced fibrosis in Stockholm, Sweden

Grip ET; Skröder H; Shang Y; Ström O; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s682

Screening for advanced fibrosis due to NAFLD in patients with type 2 diabetes in a retina scanning facility

Lindfors A; Strandberg R; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s959-s960

Four-fold increased mortality rate in patients with Wilson's disease: a population-based cohort study of 151 patients

Aberg F; Shang Y; Strandberg R; Wester A; Widman L; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s46

Risk of cancer and subsequent mortality in primary biliary cholangitis: a population-based cohort study of 3,052 patients

Wester A; Schoenau J; Schattenberg J; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s651-s652

Novel artificial intelligence-assisted digital pathology quantitative image analysis predicts the occurrence of liver-related clinical events in the multicentric, European, hepatic outcomes and survival fatty liver registry (HOTSURFR) study

Chen L; Petitjean L; Ampuero J; Boursier J; Kechagias S; Petta S; Hagstrom H; Schattenberg J; Charlotte F; Kara L; Bedossa P; Petitjean M; Ratziu V
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s607

Histological classifications versus liver-related events: results from the multicentric, European, hepatic outcomes and survival fatty liver registry (HOTSURFR) study

Ratziu V; Ampuero J; Boursier J; Kechagias S; Petta S; Hagstrom H; Schattenberg J; Belin L; Cyrille S; Charlotte F; Kara L; Bedossa P
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s276

Six-fold increased rate of chronic kidney disease after acute kidney injury: a population-based cohort study of 46,946 patients with cirrhosis

Cederborg A; Widman L; Haraldsson B; Lindkvist B; Shang Y; Wester A; Hagstrom H; Marschall H-U
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s600

Risk of bacterial infections in non-alcoholic fatty liver disease: a nationwide population-based cohort study

Wester A; Shang Y; Widman L; Ebrahimi F
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s159-s160

Disentangling the contributions of alcohol and alcohol-related liver disease towards dementia

Zhao S; Widman L; Hagstrom H; Shang Y
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s960

Risk of cirrhosis and hepatocellular carcinoma in hemochromatosis: a Swedish nationwide cohort study

Astrom H; Wester A; Widman L; Stal P; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s157-s158

Diabetes increases risk of mortality in alcohol-related liver disease

Theodoreson M; Aithal G; Allison M; Brahmania M; Forrest E; Hagstrom H; Likhitsup A; Masson S; McCune A; Rajoriya N; Rowe I; Parker R
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s653

Predicting severe liver outcomes in NAFLD using repeated measurements of biomarkers-a cohort study in 1,260 patients

Shang Y; Akbari C; Dodd M; Zhang X; Wang T; Jemielita T; Fernandes G; Engel S; Nasr P; Vessby J; Rorsman F; Kechagias S; Stal P; Ekstedt M; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s707

Performance of novel collagen turnover biomarkers in relation to FIB-4 to detect advanced fibrosis in NAFLD

Hegmar H; Moller T; Nasr P; Vessby J; Kechagias S; Nyhlin N; Marschall H-U; Borssen AD; Karsdal M; Leeming D; Ekstedt M; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s302-s303

Secondary prevention of variceal bleeding is often imperfect: a national, population-based cohort study of 5,018 patients

Hagstrom H; Shang Y; Tapper E; Wester A; Widman L
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s121

A new risk model outperforms FIB-4 when predicting incident cirrhosis in the general population: a cohort study of 504,000 persons

Strandberg R; Talback M; Hammar N; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s650-s651

Long-term liver-related outcomes in 1,260 patients with non-cirrhotic NAFLD

Akbari C; Dodd M; Zhang X; Wang T; Jemielita T; Fernandes G; Engel S; Nasr P; Vessby J; Rorsman F; Kechagias S; Stal P; Ekstedt M; Hagstrom H; Shang Y
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s88-s89

Inreased risk of hepatocellular carcinoma among first-degree relatives of patients with biopsy-proven NAFLD - a multigenerational nationwide cohort study

Ebrahimi F; Simon T; Hagstrom H; Sun J; Bergman D; Roelstraete B; Ludvigsson J
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s605

Causes of death by fibrosis stage in 959 biopsy-proven NAFLD patients

Shang Y; Akbari C; Dodd M; Nasr P; Vessby J; Rorsman F; Kechagias S; Stal P; Ekstedt M; Hagstrom H
Article: NATURE REVIEWS ENDOCRINOLOGY. 2023;19(5):299-310

Consensus Statement on the definition and classification of metabolic hyperferritinaemia.

Valenti L; Corradini E; Adams LA; Aigner E; Alqahtani S; Arrese M; Bardou-Jacquet E; Bugianesi E; Fernandez-Real J-M; Girelli D; Hagström H; Henninger B; Kowdley K; Ligabue G; McClain D; Lainé F; Miyanishi K; Muckenthaler MU; Pagani A; Pedrotti P; Pietrangelo A; Prati D; Ryan JD; Silvestri L; Spearman CW; Stål P; Tsochatzis EA; Vinchi F; Zheng M-H; Zoller H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(5):1271-1280.e7

Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study.

Wester A; Ndegwa N; Hagström H
Journal article: GASTROENTEROLOGY. 2023;164(6):s-1037

Tu1376 RISK OF HEPATITIS B INFECTION IN PEOPLE WITH CELIAC DISEASE; A POPULATION-BASED STUDY

Jossen J; Lebwohl B; Soderling J; Duberg A-S; Aleman S; Sharma R; Hagstrom H; Green PH; Ludvigsson JF
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(4):995-1004.e9

Three-fold Increased Risk of Death in Budd-Chiari Syndrome Compared to Matched Controls: A Population-based Cohort Study.

Åberg F; Rajani R; Wester A; Widman L; Hagström H
Article: NATURE. 2023;615(7950):134-142

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.

Brevini T; Maes M; Webb GJ; John BV; Fuchs CD; Buescher G; Wang L; Griffiths C; Brown ML; Scott WE; Pereyra-Gerber P; Gelson WTH; Brown S; Dillon S; Muraro D; Sharp J; Neary M; Box H; Tatham L; Stewart J; Curley P; Pertinez H; Forrest S; Mlcochova P; Varankar SS; Darvish-Damavandi M; Mulcahy VL; Kuc RE; Williams TL; Heslop JA; Rossetti D; Tysoe OC; Galanakis V; Vila-Gonzalez M; Crozier TWM; Bargehr J; Sinha S; Upponi SS; Fear C; Swift L; Saeb-Parsy K; Davies SE; Wester A; Hagström H; Melum E; Clements D; Humphreys P; Herriott J; Kijak E; Cox H; Bramwell C; Valentijn A; Illingworth CJR; UK-PBC Consortium; Dahman B; Bastaich DR; Ferreira RD; Marjot T; Barnes E; Moon AM; Barritt AS; Gupta RK; Baker S; Davenport AP; Corbett G; Gorgoulis VG; Buczacki SJA; Lee J-H; Matheson NJ; Trauner M; Fisher AJ; Gibbs P; Butler AJ; Watson CJE; Mells GF; Dougan G; Owen A; Lohse AW; Vallier L; Sampaziotis F
Article: NUTRITION JOURNAL. 2023;22(1):14

Low carbohydrate high fat-diet in real life assessed by diet history interviews.

Hagström H; Hagfors LN; Tellström A; Hedelin R; Lindmark K
Article: JOURNAL OF INHERITED METABOLIC DISEASE. 2023;46(2):286-299

Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals.

Lissing M; Vassiliou D; Floderus Y; Harper P; Yan J; Hagström H; Sardh E; Wahlin S
Article: AMERICAN HEART JOURNAL. 2023;257:33-40

Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome.

Omerovic E; James S; Erlinge D; Hagström H; Venetsanos D; Henareh L; Ekenbäck C; Alfredsson J; Hambreus K; Redfors B
Article: GUT. 2023;72(3):573-580

Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease.

Simon TG; Roelstraete B; Alkhouri N; Hagström H; Sundström J; Ludvigsson JF
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2023;57(4):418-425

Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers.

Hagström H; Yan J; Talbäck M; Andreasson A; Walldius G; Bottai M; Hammar N
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2023;11(1):79-91

Post-pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes.

Dugic A; Hagström H; Dahlman I; Rutkowski W; Daou D; Kulinski P; Löhr J-M; Vujasinovic M
Article: JOURNAL OF INTERNAL MEDICINE. 2023;293(2):184-199

Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma: A nationwide cohort study of 3473 patients.

Vaz J; Strömberg U; Midlöv P; Eriksson B; Buchebner D; Hagström H
Article: HEPATOLOGY COMMUNICATIONS. 2023;7(2):e0015

Autopsy histology data suggest cirrhosis is frequently under-reported on death certificates.

Hagström H; Simon TG; Söderling J; Ludvigsson JF
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(1):103-114.e10

Pregnancy Outcomes in Women With Autoimmune Hepatitis - A Nationwide Population-based Cohort Study With Histopathology.

Sharma R; Simon TG; Stephansson O; Verna EC; Emond J; Söderling J; Roelstraete B; Hagström H; Ludvigsson JF
Article: JHEP REPORTS. 2023;5(1):100596

Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice.

Lazarus JV; Castera L; Mark HE; Allen AM; Adams LA; Anstee QM; Arrese M; Alqahtani SA; Bugianesi E; Colombo M; Cusi K; Hagström H; Loomba R; Romero-Gómez M; Schattenberg JM; Thiele M; Valenti L; Wong VW-S; Yilmaz Y; Younossi ZM; Francque SM; Tsochatzis EA
Journal article: CLINICAL EPIDEMIOLOGY. 2023;15:753

Erratum: Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden [Corrigendum].
Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1186097

Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biology.

Stiglund N; Hagström H; Stål P; Cornillet M; Björkström NK
Journal article: GASTRO HEP ADVANCES. 2023;2(7):879-888

Risk of Cancer and Subsequent Mortality in Primary Biliary Cholangitis: A Population-based Cohort Study of 3052 Patients

Schönau J; Wester A; Schattenberg JM; Hagström H
Article: LIVER INTERNATIONAL. 2022;42(12):2769-2780

Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up.

Holmer M; Ekstedt M; Nasr P; Zenlander R; Wester A; Tavaglione F; Romeo S; Kechagias S; Stål P; Hagström H
Article: SCIENTIFIC REPORTS. 2022;12(1):20519

Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease.

Holmer M; Hagström H; Chen P; Danielsson O; Aouadi M; Rydén M; Stål P
Article: HEPATOLOGY. 2022;76(5):1495-1505

Risk of cardiovascular disease and loss in life expectancy in NAFLD.

Shang Y; Nasr P; Widman L; Hagström H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2022;57(9):1080-1088

Hepatocellular carcinoma in Stockholm, Sweden 2003-2018: a population-based cohort study.

Norén S; Bengtsson B; Hagström H; Ljunggren G; Wahlin S
Article: GUT. 2022;71(9):1867-1875

Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.

Simon TG; Roelstraete B; Hagström H; Sundström J; Ludvigsson JF
Article: JOURNAL OF INTERNAL MEDICINE. 2022;292(3):492-500

Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study.

Wester A; Hagström H
Article: NEUROLOGY. 2022;99(6):e574-e582

Nonalcoholic Fatty Liver Disease and Risk of Dementia: A Population-Based Cohort Study.

Shang Y; Widman L; Hagström H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2022;57(8):978-983

Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER).

Hagström H; Shang Y; Wester A; Widman L
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s82

OS112 Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019

Nasr P; Ndegwa N; von Seth E; Ludvigsson J; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s189

THU179 MAIT-cells in blood are associated with a higher risk of infection in patients with cirrhosis

Bengtsson B; Maucourant C; Shang Y; Sandberg JK; Björkström N; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s530

FRI275 Cancer risk in acute hepatic porphyria: a nationwide matched cohort study in 1, 245 individuals

Lissing M; Vassiliou D; Floderus Y; Yan J; Hagström H; Sardh E; Wahlin S
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s141

THU041 Refining the natural history of alcohol related liver disease: a competing risk analysis

Parker R; Aithal G; Allison M; Arab JP; Brahmania M; Forrest E; Hagström H; Likhitsup A; Masson S; McCune A; Rajoriya N; Rowe I
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s413

FRI035 Health outcomes and risk assessment in chronic liver disease (HERALD): a large Swedish research platform

Grip ET; Ström O; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s30

OS026 Liver stiffness predicts incident severe liver disease in patients with chronic liver disease

Hegmar H; Wester A; Aleman S; Backman J; Degerman E; Ekvall H; Lund K; Lundgren Å; Nasr P; Shahnavaz A; Vessby J; Westin J; Önnerhag K; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s123

THU010 Risk of fractures and subsequent mortality in alcohol-related cirrhosis: a nationwide population-based cohort study

Wester A; Ndegwa N; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s24

OS016 Prediction of ten-year risk of severe liver disease in the general population using commonly available biomarkers

Hagström H; Yan J; Talbäck M; Andreasson A; Walldius G; Bottai M; Hammar N
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s119-s120

THU002 Biomarkers for prediction of alcohol-related liver cirrhosis in the Swedish general population

Jakobsson G; Talbäck M; Walldius G; Hammar N; Shang Y; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s423

FRI053 The PNPLA3 (rs738409) G/G-genotype is associated with presence of NASH and increased long-term risk of cirrhosis in NAFLD

Holmer M; Zenlander R; Wester A; Ekstedt M; Nasr P; Kechagias S; Romeo S; Stal P; Hagström H
Article: JOURNAL OF INTERNAL MEDICINE. 2022;291(6):824-836

Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.

Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagström H; Sardh E; Wahlin S
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2022;10(5):465-476

The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population-based cohort study.

Bengtsson B; Widman L; Wahlin S; Stål P; Björkström NK; Hagström H
Article: ESC HEART FAILURE. 2022;9(3):1812-1822

Temporal trends in characteristics and outcome of heart failure patients with and without significant coronary artery disease.

Bollano E; Redfors B; Rawshani A; Venetsanos D; Völz S; Angerås O; Ljungman C; Alfredsson J; Jernberg T; Råmunddal T; Petursson P; Smith JG; Braun O; Hagström H; Fröbert O; Erlinge D; Omerovic E
Journal article: GASTROENTEROLOGY. 2022;162(7):s-1270-s-1271

Tu1310: NON-INVASIVE TESTS (NITS) FOR PREDICTING HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS WITHOUT CIRRHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INDIVIDUAL PATIENT DATA AND AGGREGATE DATA

Siriwong N; Sriphoosanaphan S; Yongpisarn T; Apiparakoon T; Tiyarattanachai T; Kerr SJ; Treeprasertsuk S; Hagstrom H; Akbari C; Ekstedt M; Ito T; Ishigami M; Toyoda H; Hino K; Kawanaka M; sumida Y; Seko Y; Peleg N; Shlomai A; Yip TCF; Wong GL; Chaiteerakij R
Article: JOURNAL OF HEPATOLOGY. 2022;76(5):1013-1020

Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events.

Boursier J; Hagström H; Ekstedt M; Moreau C; Bonacci M; Cure S; Ampuero J; Nasr P; Tallab L; Canivet CM; Kechagias S; Sánchez Y; Dincuff E; Lucena A; Roux M; Riou J; Trylesinski A; Romero-Gomez M
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022;107(5):e2008-e2020

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease.

Qadri S; Ahlholm N; Lønsmann I; Pellegrini P; Poikola A; Luukkonen PK; Porthan K; Juuti A; Sammalkorpi H; Penttilä AK; D'Ambrosio R; Soardo G; Leeming DJ; Karsdal M; Arola J; Kechagias S; Pelusi S; Ekstedt M; Valenti L; Hagström H; Yki-Järvinen H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2022;20(4):918-929.e8

Risk of Cancer in Biopsy-Proven Alcohol-Related Liver Disease: A Population-Based Cohort Study of 3410 Persons.

Hagström H; Thiele M; Sharma R; Simon TG; Roelstraete B; Söderling J; Ludvigsson JF
Article: LIVER INTERNATIONAL. 2022;42(4):820-828

Risk of hepatic and extrahepatic cancer in NAFLD: A population-based cohort study.

Björkström K; Widman L; Hagström H
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2022;10(2):198-211

Risk of infections and their role on subsequent mortality in biopsy-proven alcohol-related liver disease.

Hagström H; Thiele M; Simon TG; Sharma R; Röckert Tjernberg A; Roelstraete B; Söderling J; Ludvigsson JF
Journal article: JOURNAL OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY. 2022;5(Supplement_1):89-90

A203 INCIDENCE AND PREDICTORS OF NON-HEPATIC CANCERS IN ALCOHOL RELATED LIVER DISEASE IN THE WALDO COHORT

Hindi Z; Brahmania M; Arab J; Shi N; Rajoriya N; Aithal G; Allison M; Hagström H; Likhitsup A; McCune A; Masson S; Parker R
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2022;191(2):298-319

Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.

Sharma R; Verna EC; Simon TG; Söderling J; Hagström H; Green PHR; Ludvigsson JF
Article: NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY. 2022;19(1):60-78

Advancing the global public health agenda for NAFLD: a consensus statement.

Lazarus JV; Mark HE; Anstee QM; Arab JP; Batterham RL; Castera L; Cortez-Pinto H; Crespo J; Cusi K; Dirac MA; Francque S; George J; Hagström H; Huang TT-K; Ismail MH; Kautz A; Sarin SK; Loomba R; Miller V; Newsome PN; Ninburg M; Ocama P; Ratziu V; Rinella M; Romero D; Romero-Gómez M; Schattenberg JM; Tsochatzis EA; Valenti L; Wong VW-S; Yilmaz Y; Younossi ZM; Zelber-Sagi S; NAFLD Consensus Consortium
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2022;55(2):234-243

A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach.

Lazarus JV; Mark HE; Colombo M; Demaio S; Dillon JF; George J; Hagström H; Hocking S; Lee N; Nieuwenhuijsen MJ; Rinella ME; Romero-Gomez M; Soriano JB; Schattenberg JM; Tacke F; Tsochatzis EA; Valenti L; Zelber-Sagi S; Ashworth Dirac M; Huang TT-K
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2021;19(12):2636-2647.e13

Increased Mortality Risk in Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.

Sharma R; Verna EC; Söderling J; Roelstraete B; Hagström H; Ludvigsson JF
Article: BMC GASTROENTEROLOGY. 2021;21(1):439

Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study.

Simon TG; Hagström H; Sharma R; Söderling J; Roelstraete B; Larsson E; Ludvigsson JF
Article: JOURNAL OF HEPATOLOGY. 2021;75(5):1042-1048

Maternal obesity increases the risk and severity of NAFLD in offspring.

Hagström H; Simon TG; Roelstraete B; Stephansson O; Söderling J; Ludvigsson JF
Article: HEPATOLOGY. 2021;74(5):2410-2423

Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.

Simon TG; Roelstraete B; Sharma R; Khalili H; Hagström H; Ludvigsson JF
Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2021;33(11):1420-1426

A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis.

Björkström K; Stål P; Holmer M; Bengtsson B; Staaf A; Hoffstedt J; Hagström H
Article: NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY. 2021;18(10):717-729

Defining comprehensive models of care for NAFLD.

Lazarus JV; Anstee QM; Hagström H; Cusi K; Cortez-Pinto H; Mark HE; Roden M; Tsochatzis EA; Wong VW-S; Younossi ZM; Zelber-Sagi S; Romero-Gómez M; Schattenberg JM
Article: JHEP REPORTS. 2021;3(5):100343

External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population.

Åström H; Ndegwa N; Hagström H
Article: JOURNAL OF CLINICAL MEDICINE. 2021;10(16):3720

Vascular Complications in Patients with Chronic Pancreatitis.

Vujasinovic M; Dugic A; Nouri A; Brismar TB; Baldaque-Silva F; Asplund E; Rutkowski W; Ghorbani P; Sparrelid E; Hagström H; Löhr J-M
Article: NUTRIENTS. 2021;13(7):2386

Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis.

Vujasinovic M; Nezirevic Dobrijevic L; Asplund E; Rutkowski W; Dugic A; Kahn M; Dahlman I; Sääf M; Hagström H; Löhr J-M
Article: JOURNAL OF HEPATOLOGY. 2021;75(1):98-107

A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy.

Montagnese S; Lauridsen M; Vilstrup H; Zarantonello L; Lakner G; Fitilev S; Zupanets I; Kozlova I; Bunkova E; Tomasiewicz K; Berglund JE; Rorsman F; Hagström H; Kechagias S; Ocklind CE; Mauney J; Thunarf F; Mokhatarani M; Bäckström T; Doverskog M; Lins L-E; Månsson M; Samuelson P; Nilsson D; Schalling M; Johansson M; Arlander E; Scharschmidt BF
Article: HEPATOLOGY. 2021;74(1):474-482

Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement.

Hagström H; Adams LA; Allen AM; Byrne CD; Chang Y; Grønbaek H; Ismail M; Jepsen P; Kanwal F; Kramer J; Lazarus JV; Long MT; Loomba R; Newsome PN; Rowe IA; Ryu S; Schattenberg JM; Serper M; Sheron N; Simon TG; Tapper EB; Wild S; Wong VW-S; Yilmaz Y; Zelber-Sagi S; Åberg F
Article: GUT. 2021;70(7):1375-1382

Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.

Simon TG; Roelstraete B; Khalili H; Hagström H; Ludvigsson JF
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2021;56(6):727-732

Etiologies and outcomes of cirrhosis in a large contemporary cohort.

Hagström H; Lindfors A; Holmer M; Bengtsson B; Björkström K; Hegmar H; von Seth E
Article: JHEP REPORTS. 2021;3(3):100256

Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial.

Holmer M; Lindqvist C; Petersson S; Moshtaghi-Svensson J; Tillander V; Brismar TB; Hagström H; Stål P
Article: HEPATOLOGY COMMUNICATIONS. 2021;5(6):1021-1035

A Dynamic Aspartate-to-Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease.

Åberg F; Danford CJ; Thiele M; Talbäck M; Rasmussen DN; Jiang ZG; Hammar N; Nasr P; Ekstedt M; But A; Puukka P; Krag A; Sundvall J; Erlund I; Salomaa V; Stål P; Kechagias S; Hultcrantz R; Lai M; Afdhal N; Jula A; Männistö S; Lundqvist A; Perola M; Färkkilä M; Hagström H
Article: ENDOSCOPY INTERNATIONAL OPEN. 2021;9(5):E727-E734

Wide-field endoscopic submucosal dissection for the treatment of Barrett's esophagus neoplasia.

Omae M; Hagström H; Ndegwa N; Vieth M; Wang N; Vujasinovic M; Baldaque-Silva F
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2021;56(4):437-442

Serum levels of endotrophin are associated with nonalcoholic steatohepatitis.

Hagström H; Bu D; Nasr P; Ekstedt M; Hegmar H; Kechagias S; Zhang N; An Z; Stål P; Scherer PE
Article: JHEP REPORTS. 2021;3(2):100218

Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction.

Shang Y; Nasr P; Ekstedt M; Widman L; Stål P; Hultcrantz R; Kechagias S; Hagström H
Article: LIVER INTERNATIONAL. 2021;41(3):545-553

Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers.

Hagström H; Ndegwa N; Jalmeus M; Ekstedt M; Posserud I; Rorsman F; Nyhlin N; Klintman D; Werner M; Marschall H-U; Askling J; Stål P; Swedish Hepatology Study Group (SweHep)
Article: GUT. 2021;70(1):170-179

Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients.

Hagström H; Thiele M; Roelstraete B; Söderling J; Ludvigsson JF
Article: CLINICAL EPIDEMIOLOGY. 2021;13:21-41

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden.

Ludvigsson JF; Appelros P; Askling J; Byberg L; Carrero J-J; Ekström AM; Ekström M; Smedby KE; Hagström H; James S; Järvholm B; Michaelsson K; Pedersen NL; Sundelin H; Sundquist K; Sundström J
Article: JOURNAL OF CLINICAL MEDICINE. 2020;9(11):E3720-3720

Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis.

Vujasinovic M; Dugic A; Maisonneuve P; Aljic A; Berggren R; Panic N; Valente R; Pozzi Mucelli R; Waldthaler A; Ghorbani P; Kordes M; Hagström H; Löhr J-M
Article: JOURNAL OF HEPATOLOGY. 2020;73(5):1023-1029

Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease.

Hagström H; Talbäck M; Andreasson A; Walldius G; Hammar N
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2020;5(11):1008-1016

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.

Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana M-A; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(10):1205-1210

Validity of administrative codes associated with cirrhosis in Sweden.

Bengtsson B; Askling J; Ludvigsson JF; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s178

THU077 Mortality in biopsy-proven alcohol-related liver disease: population-based cohort study of 3,453 individuals

Hagström H; Thiele M; Roelstraete B; Söderling J; Ludvigsson JF
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s371-s372

THU466 Long-term risk of HCC in persons with cirrhosis: national, population-based cohort study of 7,322 individuals

Bengtsson B; Widman L; Wahlin S; Stal P; Björkström N; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s63

AS086 Primary liver cancer in acute hepatic porphyria: a national cohort study

Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagström H; Sardh E; Wahlin S
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s166-s167

THU053 Europe’s largest meta-analysis on the prevalence of non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and advanced fibrosis (F3-F4)

Petta S; Hagström H; Geier A; Ratziu V; Caballeria L; Expósito C; Hernández R; Blokzijl H; De Knegt R; Ferrinho D; Ntalla I; Smith A; Ramroth H; Newsome PN
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s128-s129

LBP10 Bariatric surgery is not associated with a reduction in risk of severe liver disease in comparison to standard obesity treatment in 3,922 subjects

Hagström H; Ekstedt M; Olbers T; Peltonen M; Carlsson L
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s108

AS157 Liver disease progression and clinical outcomes in hepatic outcomes and survival fatty liver registry (HOTSURFR) study

Kutala B; Boursier J; Ekstedt M; Hagström H; Pais R; Bugianesi E; George J; Schattenberg JM; Anstee Q; Bedossa P; Ratziu V
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s541

FRI285 Prognosis in persons with an HFE-mutation: population-based cohort study of 3,645 individuals

Hagström H; Ndegwa N; Ekstedt M; Posserud I; Rorsman F; Nyhlin N; Klintman D; Werner M; Marschall H-U; Askling J; Stal P
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s420

FRI040 Macrophage markers do not add to the prediction of liver fibrosis by transient elastography in patients with non-alcoholic fatty liver disease

Kazankov K; Rosso C; Younes R; Hagström H; Møller HJ; Stal P; Bugianesi E; Grønbæk H
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s70-s71

AS096 Repeated measures of FIB-4 improve prediction of severe liver disease: population-based cohort study of 40,729 individuals

Hagström H; Talbäck M; Andreasson A; Walldius G; Hammar N
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2020;18(7):1592-1599.e8

Health Care Costs of Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease Are Nearly Twice Those of Matched Controls.

Hagström H; Nasr P; Ekstedt M; Hammar U; Widman L; Stål P; Hultcrantz R; Kechagias S; Henriksson M
Journal article: GASTROENTEROLOGY. 2020;158(6):s-1285-s-1286

690 MORTALITY RISK IN BIOPSY-VERIFIED AUTOIMMUNE HEPATITIS: A NATIONWIDE POPULATION-BASED COHORT STUDY

Sharma R; Verna EC; Soderling J; Roelstraete B; Hagstrom H; Ludvigsson JF
Article: EUROPEAN HEART JOURNAL - CASE REPORTS. 2020;4(1):1-6

Lomitapide treatment in a female with homozygous familial hypercholesterolaemia: a case report.

Littmann K; Szummer K; Hagström H; Dolapcsiev K; Brinck J; Eriksson M
Article: CLINICAL EPIDEMIOLOGY. 2020;12:1433-1442

Incidence of ICD-Based Diagnoses of Alcohol-Related Disorders and Diseases from Swedish Nationwide Registers and Suggestions for Coding.

Bergman D; Hagström H; Capusan AJ; Mårild K; Nyberg F; Sundquist K; Ludvigsson JF
Article: FRONTIERS IN MEDICINE. 2020;7:616212

Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease.

Kazankov K; Rosso C; Younes R; Armandi A; Hagström H; Møller HJ; Stål P; Bugianesi E; Grønbæk H
Article: GASTROENTEROLOGY. 2020;158(1):200-214

Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease.

Hagström H; Talbäck M; Andreasson A; Walldius G; Hammar N
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2019;17(13):2769-2775.e4

Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes.

Björkström K; Franzén S; Eliasson B; Miftaraj M; Gudbjörnsdottir S; Trolle-Lagerros Y; Svensson A-M; Hagström H
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2019;7(9):1250-1260

The prediction of colorectal cancer using anthropometric measures: A Swedish population-based cohort study with 22 years of follow-up.

Andreasson A; Hagström H; Sköldberg F; Önnerhag K; Carlsson AC; Schmidt PT; Forsberg AM
Article: ANNALS OF INTERNAL MEDICINE. 2019;171(5):318-327

Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.

Simon TG; Duberg A-S; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(4):294-299

The use of anthropometric measures in the prediction of incident gout: results from a Swedish community-based cohort study.

Wändell P; Andreasson A; Hagström H; Kapetanovic MC; Carlsson AC
Article: DIGESTIVE DISEASES AND SCIENCES. 2019;64(7):2014-2023

Risk Behaviors Associated with Alcohol Consumption Predict Future Severe Liver Disease.

Hagström H; Hemmingsson T; Discacciati A; Andreasson A
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2019;54(6):761-765

Transient liver elastography in normal pregnancy - a longitudinal cohort study.

Stenberg Ribeiro M; Hagström H; Stål P; Ajne G
Article: LIVER INTERNATIONAL. 2019;39(6):1098-1108

Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.

Bengtsson B; Stål P; Wahlin S; Björkström NK; Hagström H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2019;17(6):1148-1156.e4

Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease.

Hagström H; Nasr P; Ekstedt M; Stål P; Hultcrantz R; Kechagias S
Journal article: JOURNAL OF HEPATOLOGY. 2019;70(1):e766-e767

SAT-297-Prediction of incident severe liver disease in the general population using non-invasive scoring systems

Hagström H; Talbäck M; Andreasson A; Carlsson A; Walldius G; Hammar N
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2019;49(6):789-796

Body mass index in early pregnancy and future risk of severe liver disease: a population-based cohort study.

Hagström H; Höijer J; Andreasson A; Bottai M; Johansson K; Ludvigsson JF; Stephansson O
Article: LIVER INTERNATIONAL. 2019;39(1):197-204

Cardiovascular risk factors in non-alcoholic fatty liver disease.

Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Askling J; Hultcrantz R; Kechagias S
Article: PLOS ONE. 2019;14(9):e0223312

Association between temperature, sunlight hours and alcohol consumption.

Hagström H; Widman L; von Seth E
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:1255

Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease.

Stiglund N; Strand K; Cornillet M; Stål P; Thorell A; Zimmer CL; Näslund E; Karlgren S; Nilsson H; Mellgren G; Fernø J; Hagström H; Björkström NK
Article: HEPATOLOGY COMMUNICATIONS. 2018;2(11):1299-1305

Outcomes of Pregnancy in Mothers With Cirrhosis: A National Population-Based Cohort Study of 1.3 Million Pregnancies.

Hagström H; Höijer J; Marschall H-U; Williamson C; Heneghan MA; Westbrook RH; Ludvigsson JF; Stephansson O
Article: LIVER INTERNATIONAL. 2018;38(11):2082-2090

Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries.

Holmer M; Melum E; Isoniemi H; Ericzon B-G; Castedal M; Nordin A; Aagaard Schultz N; Rasmussen A; Line P-D; Stål P; Bennet W; Hagström H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2018;16(9):1474-1480.e1

Lifestyle Factors in Late Adolescence Associate With Later Development of Diverticular Disease Requiring Hospitalization.

Järbrink-Sehgal ME; Schmidt PT; Sköldberg F; Hemmingsson T; Hagström H; Andreasson A
Article: HEPATOLOGY. 2018;68(2):625-633

Pregnancy outcome in women undergoing liver biopsy during pregnancy: A nationwide population-based cohort study.

Ludvigsson JF; Marschall H-U; Hagström H; Höijer J; Stephansson O
Article: GUT. 2018;67(8):1536-1542

High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men.

Hagström H; Tynelius P; Rasmussen F
Article: GASTROENTEROLOGY RESEARCH AND PRACTICE. 2018;2018:1942648-7

Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease.

Hagström H; Elfwén O; Hultcrantz R; Stål P
Article: LIVER INTERNATIONAL. 2018;38(5):885-894

Quality of life as a prognostic factor for survival in hepatocellular carcinoma.

Sternby Eilard M; Hagström H; Mortensen KE; Wilsgaard T; Vagnildhaug OM; Dajani O; Stål P; Rizell M
Article: DIGESTIVE DISEASES AND SCIENCES. 2018;63(5):1348-1354

Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.

Efe C; Taii HA; Ytting H; Aehling N; Bhanji RA; Hagström H; Purnak T; Muratori L; Werner M; Muratori P; Klintman D; Schiano TD; Montano-Loza AJ; Berg T; Larsen FS; Alkhouri N; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
Journal article: JOURNAL OF HEPATOLOGY. 2018;68:s823

SAT-485 Risk factors for development of severe liver disease in more than 400 000 patients with type 2 diabetes: A population-based cohort study

Björkström K; Franzén S; Eliasson B; Miftaraj M; Gudbjornsdottir S; Trolle-Lagerros Y; Svensson A-M; Hagström H
Article: JOURNAL OF HEPATOLOGY. 2018;68(3):505-510

Alcohol consumption in late adolescence is associated with an increased risk of severe liver disease later in life.

Hagström H; Hemmingsson T; Discacciati A; Andreasson A
Article: HEPATOLOGY COMMUNICATIONS. 2018;2(1):48-57

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study.

Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
Article: PLOS ONE. 2018;13(8):e0202651

Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up.

Hagström H; Andreasson A; Carlsson AC; Jerkeman M; Carlsten M
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2017;52(12):1427-1434

IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.

Hagström H; Stål P; Hultcrantz R; Brismar K; Ansurudeen I
Journal article: JOURNAL OF HEPATOLOGY. 2017;67(6):1134-1136

Back to Byzance: Querelles byzantines over NASH and fibrosis.

Ratziu V
Article: JOURNAL OF HEPATOLOGY. 2017;67(6):1265-1273

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.

Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2017;15(12):1950-1956.e1

Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis.

Efe C; Hagström H; Ytting H; Bhanji RA; Müller NF; Wang Q; Purnak T; Muratori L; Werner M; Marschall H-U; Muratori P; Gunşar F; Klintman D; Parés A; Heurgué-Berlot A; Schiano TD; Cengiz M; May-Sien Tana M; Ma X; Montano-Loza AJ; Berg T; Verma S; Larsen FS; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
Article: BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY. 2017;31(5):537-543

Alcohol, smoking and the liver disease patient.

Hagström H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2017;15(9):1461-1468

Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease.

Björkström K; Stål P; Hultcrantz R; Hagström H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2017;15(8):1294-1301.e2

Waist/Hip Ratio Better Predicts Development of Severe Liver Disease Within 20 Years Than Body Mass Index: A Population-based Cohort Study.

Andreasson A; Carlsson AC; Önnerhag K; Hagström H
Article: LAKARTIDNINGEN. 2017;114:EFMD

[New guidelines for NAFLD – a Swedish perspective].

Hagström H; Hoffstedt J; Reynisdottir S
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2017;52(2):159-165

Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.

Hagström H; Nasr P; Ekstedt M; Kechagias S; Önnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall H-U; Hultcrantz R; Stål P
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2017;52(1):87-91

SAF score and mortality in NAFLD after up to 41 years of follow-up.

Hagström H; Nasr P; Ekstedt M; Kechagias S; Stål P; Bedossa P; Hultcrantz R
Article: LIVER INTERNATIONAL. 2016;36(11):1688-1695

Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up.

Hagström H; Nasr P; Bottai M; Ekstedt M; Kechagias S; Hultcrantz R; Stål P
Article: JOURNAL OF HEPATOLOGY. 2016;65(2):363-368

Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study.

Hagström H; Stål P; Hultcrantz R; Hemmingsson T; Andreasson A
Article: LIVER INTERNATIONAL. 2016;36(2):268-274

Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease.

Hagström H; Höijer J; Ludvigsson JF; Bottai M; Ekbom A; Hultcrantz R; Stephansson O; Stokkeland K
Article: PLOS ONE. 2016;11(12):e0167776

Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.

Lykiardopoulos B; Hagström H; Fredrikson M; Ignatova S; Stål P; Hultcrantz R; Ekstedt M; Kechagias S
Article: HEPATOLOGY. 2015;61(5):1547-1554

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

Ekstedt M; Hagström H; Nasr P; Fredrikson M; Stål P; Kechagias S; Hultcrantz R
Article: WORLD JOURNAL OF GASTROENTEROLOGY. 2012;18(24):3105-3111

Alcohol consumption in patients with primary sclerosing cholangitis.

Hagström H; Stål P; Stokkeland K; Bergquist A
Journal article: MOLECULAR HUMAN REPRODUCTION. 1999;5(8):714-719

Cell characteristics and function of two enriched fraction of human luteal cells prolonged culture.

Fridén BE; Hagström H; Lindblom B; Sjöblom P; Wallin A; Brännström M; Hahlin M
Journal article: HUMAN REPRODUCTION. 1997;12(Suppl_2):234-235

P-246. Co-culture of human trophoblastic and corpus luteum cells in vitro : a pilot study

Fridén BE; Hagström H-G; Brännström M; Lindblom B; Hahlin M; Sjöblom P
Visa fler

Alla övriga publikationer

Review: JOURNAL OF HEPATOLOGY. 2024;81(1):149-162

Developing and validating clinical prediction models in hepatology - An overview for clinicians.

Strandberg R; Jepsen P; Hagström H
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(3):670

Reply.

Hagström H; Shang Y; Tapper EB; Wester A; Widman L
Review: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2024;12(2):168-176

Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease.

Hagström H; Hegmar H; Moreno C
Corrigendum: NATURE REVIEWS ENDOCRINOLOGY. 2024;20(3):185

Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia.

Valenti L; Corradini E; Adams LA; Aigner E; Alqahtani S; Arrese M; Bardou-Jacquet E; Bugianesi E; Fernandez-Real J-M; Girelli D; Hagström H; Henninger B; Kowdley K; Ligabue G; McClain D; Lainé F; Miyanishi K; Muckenthaler MU; Pagani A; Pedrotti P; Pietrangelo A; Prati D; Ryan JD; Silvestri L; Spearman CW; Stål P; Tsochatzis EA; Vinchi F; Zheng M-H; Zoller H
Letter: GUT. 2024;:gutjnl-2023-331331

Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD.

Shang Y; Akbari C; Dodd M; Nasr P; Vessby J; Rorsman F; Kechagias S; Stål P; Ekstedt M; Hagström H
Letter: JOURNAL OF HEPATOLOGY. 2024;80(2):e76-e77

99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical.

Hagström H; Vessby J; Ekstedt M; Shang Y
Conference publication: ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2024;62(01):e15

Lower incidence of HCC and other major adverse liver outcomes in people living with HIV and chronic liver disease: a population-based cohort study

Michel M; Hagström H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Letter: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2023;11(9):906

Challenges with neuropsychiatric Wilson's disease.

Åberg F; Hagström H
Letter: JOURNAL OF INTERNAL MEDICINE. 2023;294(4):537-538

Authors reply: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis.

Schönau J; Wester A; Hagström H; Schattenberg JM
Preprint: BIORXIV. 2023

Estrogen receptor activation remodelsTEAD1gene expression to alleviate nonalcoholic fatty liver disease

Sommerauer C; Gallardo-Dodd C; Savva C; Hases L; Birgersson M; Indukuri R; Shen J; Carravilla P; Geng K; Nørskov Søndergaard J; Ferrer-Aumatell C; Mercier G; Sezgin E; Korach-André M; Petersson C; Hagström H; Lauschke V; Archer A; Williams C; Kutter C
Editorial comment: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(10):2689-2691.e1

Minimal Risk of Hepatocellular Carcinoma in Noncirrhotic Budd-Chiari Syndrome: A Three-Decade Population-Based Study.

Wester A; Åberg F; Rajani R; Hagström H
Review: JOURNAL OF HEPATOLOGY. 2023;79(3):842-852

Changing epidemiology, global trends and implications for outcomes of NAFLD.

Wong VW-S; Ekstedt M; Wong GL-H; Hagström H
Conference publication: ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2023;61(08):e472-e473

Lower incidence of HCC and other major adverse liver outcomes in people living with HIV and chronic liver disease: a population-based cohort study

Michel M; Hagström H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(6):1678

Reply.

Wester A; Hagström H
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(5):1359-1361.e2

Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects.

Shang Y; Hagström H
Review: LIVER INTERNATIONAL. 2023;43(4):763-772

Extra-hepatic morbidity and mortality in alcohol-related liver disease: Systematic review and meta-analysis.

Theodoreson MD; Aithal GP; Allison M; Brahmania M; Forrest E; Hagström H; Johansen S; Krag A; Likhitsup A; Masson S; McCune A; Rajoriya N; Thiele M; Rowe IA; Parker R
Letter: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2023;57(6):737-738

Letter: comment on Park et al - the association of non-alcoholic fatty liver disease between parents and adolescent children.

Hagström H; Ludvigsson JF
Editorial comment: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2023;57(6):728

Editorial: moving from the clinic towards population hepatology-authors' reply.

Hagström H; Hammar N
Letter: JOURNAL OF HEPATOLOGY. 2023;78(2):e66-e67

Considerations in the search for under-reported alcohol consumption in NAFLD.

Hagström H; Ekstedt M
Editorial comment: HEPATOLOGY. 2023;77(2):350-351

Less is more? Screening for steatosis in older populations.

Hagström H; Shang Y
Editorial comment: HEPATOLOGY. 2023;77(1):18-19

A new model for estimation of significant fibrosis in primary care. SAFE to use?

Hagström H
Conference publication: JOURNAL OF HEPATOLOGY. 2023;78:S654

Prevalence of NAFLD and advanced fibrosis in Stockholm, Sweden

Grip ET; Skroder H; Shang Y; Strom O; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2023;78:S857

Healthcare resource use and costs among patients with primary sclerosing cholangitis in Sweden-a retrospective population-based cohort study

Bergquist A; Kachru N; Aldven M; Strom O; Knutsson D; Grip ET; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2023;78:S710

Implementing a clinical care algorithm for screening of liver fibrosis in specialist diabetes care

Tajudin M; Hoffstedt J; Hagstrom H; Rossner S
Conference publication: HEPATOLOGY. 2023;78:S969-S971

HISTOLOGICAL CLASSIFICATIONS AND PREDICTION OF LIVER- RELATED EVENTS : RESULTS FROM THE MULTICENTRIC, EUROPEAN, HEPATIC OUTCOMES AND SURVIVAL FATTY LIVER REGISTRY ( HOTSURFR) STUDY

Ratziu V; Ampuero J; Boursier J; Kechagias S; Petta S; Hagstrom H; Schattenberg JM; Belin L; Charlotte F; Kara L
Conference publication: HEPATOLOGY. 2023;78:S1668-S1669

UPTAKE OF SECONDARY PREVENTIVE DRUGS AFTER MYOCARDIAL INFARCTION IN PATIENTS WITH ALCOHOL-RELATED LIVER DISEASE IS LOW: A NATIONWIDE POPULATION-BASED STUDY

Wester A; Hagstrom H; Jepsen P
Conference publication: HEPATOLOGY. 2023;78:S876-S880

SERIAL VIBRATION CONTROLLED TRANSIENT ELASTOGRAPHY (VCTE)-BASED AGILE SCORES PREDICT LIVER-RELATED EVENTS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) - A MULTICENTER COHORT STUDY OF 16,603 PATIENTS

Lin H; Lee HW; Yip TC-F; Tsochatzis EA; Petta S; Bugianesi E; Yoneda M; Zheng M-H; Hagstrom H; Boursier J; Luis Calleja J; Goh GB-B; Chan WK; Romero-Gomez M; Sanyal A; De Ledinghen V; Newsome PN; Fan J-G; Castera L; Lai M; Harrison SA; Fournier-Poizat CD; Wong GL-H; Pennisi G; Armandi A; Nakajima A; Liu WY; Shang Y; De Saint Loup M; Llop E; Teh KKJ; Lara Romero C; Asgharpour A; Mahgoub S; Chan M; Canivet C; Gallego-Duran R; Kim SU; Wong VW-S
Conference publication: HEPATOLOGY. 2023;78:S853-S854

NOVEL ARTIFICIAL INTELLIGENCE-ASSISTED DIGITAL PATHOLOGY QUANTITATIVE IMAGE ANALYSIS PREDICTS THE OCCURRENCE OF LIVER-RELATED CLINICAL EVENTS IN THE MULTICENTRIC, EUROPEAN, HEPATIC OUTCOMES AND SURVIVAL FATTY LIVER REGISTRY (HOTSURFR) STUDY

Chen L; Petitjean L; Ampuero J; Boursier J; Kechagias S; Petta S; Hagstrom H; Schattenberg JM; Charlotte F; Kara L; Bedossa P; Petitjean MM; Ratziu V
Conference publication: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2023;38:96

Sixfold increased risk of acute pancreatitis in patients with alcohol-related liver disease compared with matched controls: A nationwide population-based cohort study

Dugic A; Widman L; Hagstroem H
Conference publication: HEPATOLOGY. 2023;78:S928-S931

CLASSIFICATION ACCORDING TO SEQUENTIALLY COMBINED NON-INVASIVE TESTS CARRIES PROGNOSTIC VALUE IN PATIENTS WITH NAFLD

Mozes FE; Kaur S; Vali Y; Alzoubi O; Wong VW-S; Li G; Wong GL-HC; Staufer K; Trauner M; Paternostro R; Stauber RE; Bugianesi E; Gaia S; Armandi A; Lupsor-Platon M; Sebastiani G; Mahadeva S; Rajaram R; Zheng M-H; George J; Eslam MM; Pennisi G; Aithal GP; Palaniyappan N; Lee D; Nasr P; Cassinotto C; De Ledinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Boursier J; De Saint Loup M; Hirooka M; Shima T; Shalimar; Hagstrom H; Ekstedt M; Akbari C; Chan WK; Tsochatzis EA; Liguori A; Petta S; Vigano M; Ridolfo S; Yoneda M; Nakajima A; Holleboom AG; Van Dijk A-M; Mak AL; Cobbold JFL; Karlas T; Wiegand J; Fournier C; Martic M; Tuthill T; Yunis C; Anstee QM; Harrison S; Bossuyt P; Pavlides M
Book chapter: ALCOHOL AND ALCOHOL-RELATED DISEASES. 2023;p. 953-973

Modulation of Alcohol-Related Liver Disease by Obesity and Diabetes

Hegmar H; Hagström H
Conference publication: HEPATOLOGY. 2023;78:S395-S396

LOWER INCIDENCE OF HCC AND OTHER MAJOR ADVERSE LIVER OUTCOMES IN PEOPLE LIVING WITH HIV AND CHRONIC LIVER DISEASE: A POPULATION-BASED COHORT STUDY

Michel M; Hagstrom H; Widman L; Nowak P; Shang Y; Schattenberg J; Wester A
Conference publication: HEPATOLOGY. 2023;78:S1018-S1020

NASH SEVERITY ASSESSED BY THE NAFLD ACTIVITY SCORE (NAS) DOES NOT ADD PROGNOSTIC INFORMATION TO FIBROSIS STAGE IN PATIENTS WITH NAFLD

Mozes FE; Kaur S; Vali Y; Alzoubi O; Wong VW-S; Li G; Wong GL-HC; Staufer K; Trauner M; Paternostro R; Stauber RE; Bugianesi E; Gaia S; Armandi A; Lupsor-Platon M; Sebastiani G; Mahadeva S; Rajaram R; Zheng M-H; George J; Eslam MM; Pennisi G; Aithal GP; Palaniyappan N; Lee D; Nasr P; Cassinotto C; De Ledinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Boursier J; De Saint Loup M; Hirooka M; Shima T; Dr S; Hagstrom H; Ekstedt M; Akbari C; Chan WK; Tsochatzis EA; Liguori A; Petta S; Vigano M; Ridolfo S; Yoneda M; Nakajima A; Holleboom AG; Van Dijk A-M; Mak AL; Cobbold JFL; Karlas T; Wiegand J; Fournier C; Martic M; Tuthill T; Yunis C; Anstee QM; Harrison S; Bossuyt P; Pavlides M
Conference publication: HEPATOLOGY. 2023;78:S995-S998

LIVER STIFFNESS MEASUREMENT BASED COMPOSITE SCORES HAVE COMPARABLE PROGNOSTIC PERFORMANCE TO HISTOLOGICALLY ASSESSED FIBROSIS STAGE

Mozes FE; Kaur S; Vali Y; Alzoubi O; Wong VW-S; Li G; Wong GL-HC; Staufer K; Trauner M; Paternostro R; Stauber RE; Bugianesi E; Gaia S; Armandi A; Lupsor-Platon M; Sebastiani G; Mahadeva S; Rajaram R; Zheng M-H; George J; Eslam MM; Pennisi G; Aithal GP; Palaniyappan N; Lee D; Nasr P; Cassinotto C; De Ledinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Boursier J; De Saint Loup M; Hirooka M; Shima T; Dr S; Hagstrom H; Ekstedt M; Akbari C; Chan WK; Tsochatzis EA; Liguori A; Petta S; Vigano M; Ridolfo S; Yoneda M; Nakajima A; Holleboom AG; Van Dijk A-M; Mak AL; Cobbold JFL; Karlas T; Wiegand J; Fournier C; Martic M; Tuthill T; Yunis C; Anstee QM; Harrison S; Bossuyt P; Pavlides M
Conference publication: HEPATOLOGY. 2023;78:S971-S974

HISTOLOGICALLY ASSESSED FIBROSIS IS THE MAIN DETERMINANT OF PROGNOSIS IN PATIENTS IN NAFLD

Mozes FE; Kaur S; Vali Y; Alzoubi O; Wong VW-S; Li G; Wong GL-HC; Staufer K; Trauner M; Paternostro R; Stauber RE; Bugianesi E; Gaia S; Armandi A; Lupsor-Platon M; Sebastiani G; Mahadeva S; Rajaram R; Zheng M-H; George J; Eslam MM; Pennisi G; Aithal GP; Palaniyappan N; Lee D; Nasr P; Cassinotto C; De Ledinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Boursier J; De Saint Loup M; Hirooka M; Shima T; Shalimar; Hagstrom H; Ekstedt M; Akbari C; Chan WK; Tsochatzis EA; Liguori A; Petta S; Vigano M; Ridolfo S; Yoneda M; Nakajima A; Holleboom AG; Van Dijk A-M; Mak AL; Cobbold JFL; Karlas T; Wiegand J; Fournier C; Martic M; Tuthill T; Yunis C; Anstee QM; Harrison S; Bossuyt P; Pavlides M
Conference publication: HEPATOLOGY. 2023;78:S932-S935

COMPOSITE SCORES THAT INCLUDE LIVER STIFFNESS MEASUREMENT CAN PREDICT OUTCOMES IN PATIENTS WITH NAFLD

Mozes FE; Kaur S; Vali Y; Alzoubi O; Wong VW-S; Li G; Wong GL-HC; Staufer K; Trauner M; Paternostro R; Stauber RE; Bugianesi E; Gaia S; Armandi A; Lupsor-Platon M; Sebastiani G; Mahadeva S; Rajaram R; Zheng M-H; George J; Eslam MM; Pennisi G; Aithal GP; Palaniyappan N; Lee D; Nasr P; Cassinotto C; De Ledinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Boursier J; De Saint Loup M; Hirooka M; Shima T; Shalimar D; Hagstrom H; Ekstedt M; Akbari C; Chan WK; Tsochatzis EA; Liguori A; Petta S; Vigano M; Ridolfo S; Yoneda M; Nakajima A; Holleboom AG; Van Dijk A-M; Mak AL; Cobbold JFL; Karlas T; Wiegand J; Fournier C; Martic M; Tuthill T; Yunis C; Anstee QM; Harrison S; Bossuyt P; Pavlides M
Conference publication: PANCREATOLOGY. 2022;22:e2-e3

Post-pancreatitis diabetes mellitus Ц a high-volume tertiary center experience

Dugic A; Hagström H; Dahlman I; Rutkowski W; Daou D; Kulinski P; Löhr M; Vujasinovic M
Other: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2022;10(8):898

In memoriam: Rolf Hultcrantz (1949-2022).

Hagström H; Simrén M; Ekbom A
Review: JOURNAL OF INTERNAL MEDICINE. 2022;292(2):177-189

Risk for hepatic and extra-hepatic outcomes in nonalcoholic fatty liver disease.

Hagström H; Kechagias S; Ekstedt M
Conference publication: HEPATOLOGY. 2022;76:S800-S801

THE RELATIONSHIP BETWEEN LIVER HISTOLOGY AND LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A REAL-WORLD COHORT STUDY

Younossi ZM; Mangla KK; Berentzen TL; Grau K; Kjaer MS; Ladelund S; Nitze LM; Coolbaugh C; Hsu C-Y; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S818-S820

REAL-WORLD EVIDENCE ON NON-INVASIVE TESTS AND ASSOCIATED CUT-OFFS USED TO ASSESS FIBROSIS IN ROUTINE CLINICAL PRACTICE

Lazarus JV; Castera L; Mark H; Adams LA; Allen AM; Anstee QM; Arrese M; Alqahtani S; Bugianesi E; Colombo M; Cusi K; Hagstrom H; Loomba R; Romero-Gomez M; Schattenberg JM; Thiele M; Valenti L; Wong V; Yilmaz Y; Younossi ZM; Francque SM; Tsochatzis EA
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S141

Refining the natural history of alcohol related liver disease: a competing risk analysis

Parker R; Aithal G; Allison M; Arab JP; Brahmania M; Forrest E; Hagstrom H; Likhitsup A; Masson S; McCune A; Rajoriya N; Rowe I
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S413

Health outcomes and risk assessment in chronic liver disease (HERALD): a large Swedish research platform

Grip ET; Strom O; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S8-S10

PROGNOSTIC VALUE OF NON-INVASIVE TESTS IN PATIENTS WITH NAFLD

Mozes FE; Lee J; Alzoubi O; Wong V; Li G; Wong GL; Boursier J; Saint Loup MD; Hirooka M; Shima T; Shalimar; Hagstrom H; Ekstedt M; Akbari C; Chan WK; Tsochatzis EA; Liguori A; Petta S; Vigano M; Ridolfo S; Yoneda M; Nakajima A; Holleboom AG; Van Dijk A-M; Mak AL; Cobbold JF; Karlas T; Wiegand J; Fournier CD; Martic M; Tuthill T; Yunis C; Anstee QM; Harrison SA; Bossuyt P; Pavlides M
Conference publication: GASTROENTEROLOGY. 2022;162(7):S1270-S1271

NON-INVASIVE TESTS (NITS) FOR PREDICTING HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS WITHOUT CIRRHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INDIVIDUAL PATIENT DATA AND AGGREGATE DATA

Siriwong N; Sriphoosanaphan S; Yongpisarn T; Apiparakoon T; Tiyarattanachai T; Kerr SJ; Treeprasertsuk S; Hagstrom H; Akbari C; Ekstedt M; Ito T; Ishigami M; Toyoda H; Hino K; Kawanaka M; Sumida Y; Seko Y; Peleg N; Shlomai A; Yip TCF; Wong GL; Chaiteerakij R
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S189

MAIT-cells in blood are associated with a higher risk of infection in patients with cirrhosis

Bengtsson B; Maucourant C; Shang Y; Sandberg JK; Bjorkstrom N; Hagstrom H
Conference publication: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2022;37:48

Post-pancreatitis diabetes mellitus: A high-volume tertiary center experience

Dugic A; Hagstrom H; Dahlman I; Rutkowski W; Daou D; Kulinski P; Lohr JM; Vujasinovic M
Conference publication: HEPATOLOGY. 2022;76:S1133-S1134

RISK OF INJURY BEFORE AND AFTER DIAGNOSIS OF CIRRHOSIS: A SELF-CONTROLLED CASE SERIES STUDY

Shang Y; Shen Q; Tapper EB; Wester A; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S423

The PNPLA3 (rs738409) G/G-genotype is associated with presence of NASH and increased long-term risk of cirrhosis in NAFLD

Holmer M; Zenlander R; Wester A; Ekstedt M; Nasr P; Kechagias S; Romeo S; Stal P; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S30

Liver stiffness predicts incident severe liver disease in patients with chronic liver disease

Hegmar H; Wester A; Aleman S; Backman J; Degerman E; Ekvall H; Lund K; Lundgren A; Nasr P; Shahnavaz A; Vessby J; Westin J; Onnerhag K; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S1491

RISK OF FRACTURES AND POST-FRACTURE MORTALITY IN PRIMARY BILIARY CHOLANGITIS: A POPULATION-BASED COHORT STUDY OF 3,980 PATIENTS

Wester A; Schoenau J; Schattenberg JM; Hagstroem H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S82

Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019

Nasr P; Ndegwa N; von Seth E; Ludvigsson J; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S949

TIME TRENDS FOR MORTALITY AND LIFE EXPECTANCY IN 22,658 PATIENTS HOSPITALIZED WITH ALCOHOL-RELATED CIRRHOSIS IN SWEDEN: A NATIONWIDE COHORT STUDY

Wester A; Shang Y; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S24

Prediction of ten-year risk of severe liver disease in the general population using commonly available biomarkers

Hagstrom H; Yan J; Talback M; Andreasson A; Walldius G; Bottai M; Hammar N
Conference publication: DIABETOLOGIA. 2022;65(SUPPL 1):S9

Increased risk for microvascular outcome in NAFLD: a nationwide, population-based cohort study

Ebert T; Widman L; Stenvinkel P; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S119-S120

Biomarkers for prediction of alcohol-related liver cirrhosis in the Swedish general population

Jakobsson G; Talback M; Walldius G; Hammar N; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S620-S621

ADDITIONAL COMPONENTS OF THE METABOLIC SYNDROMES INCREASE THE RISK FOR SEVERE LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES IN A DOSE-DEPENDENT MANNER

Shang Y; Toresson-Grip E; Ntanios F; Modica A; Strom O; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S123

Risk of fractures and subsequent mortality in alcohol-related cirrhosis: a nationwide population-based cohort study

Wester A; Ndegwa N; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S530

Cancer risk in acute hepatic porphyria: a nationwide matched cohort study in 1, 245 individuals

Lissing M; Vassiliou D; Floderus Y; Yan J; Hagstrom H; Sardh E; Wahlin S
Letter: JHEP REPORTS. 2021;3(6):100366

Reply to: "Reduced steatosis and weight as a result of specific diets or the dietitian themselves".

Holmer M; Lindqvist C; Hagström H; Stål P
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2021;19(12):2675-2676.e2

Bariatric Surgery Versus Standard Obesity Treatment and the Risk of Severe Liver Disease: Data From the Swedish Obese Subjects Study.

Hagström H; Ekstedt M; Olbers T; Peltonen M; Carlsson L
Review: JOURNAL OF INTERNAL MEDICINE. 2021;290(3):602-620

Technological readiness and implementation of genomic-driven precision medicine for complex diseases.

Franks PW; Melén E; Friedman M; Sundström J; Kockum I; Klareskog L; Almqvist C; Bergen SE; Czene K; Hägg S; Hall P; Johnell K; Malarstig A; Catrina A; Hagström H; Benson M; Gustav Smith J; Gomez MF; Orho-Melander M; Jacobsson B; Halfvarson J; Repsilber D; Oresic M; Jern C; Melin B; Ohlsson C; Fall T; Rönnblom L; Wadelius M; Nordmark G; Johansson Å; Rosenquist R; Sullivan PF
Preprint: MEDRXIV. 2021

A Sustainable Development Goal framework to guide multisectoral action on NAFLD through a societal approach

Lazarus JV; Mark HE; Colombo M; Demaio S; Dillon JF; George J; Hagström H; Hocking S; Lee N; Nieuwenhuijsen MJ; Rinella ME; Romero-Gomez M; Soriano JB; Schattenberg JM; Tacke F; Tsochatzis EA; Valenti L; Zelber-Sagi S; Dirac MA; Huang TT-K
Conference publication: PANCREATOLOGY. 2021;21:s38

Risk of developing pancreatic cancer in patients with chronic pancreatitis

Vujasinovic M; Dugic A; Maisonneuve P; Aljic A; Berggren R; Panic N; Valente R; Mucelli RP; Waldthaler A; Ghorbani P; Kordes M; Hagström H; Löhr M
Conference publication: HEPATOLOGY. 2021;74:219A-220A

INCIDENCE AND PREDICTORS OF NON-HEPATIC CANCERS IN ALCOHOL RELATED LIVER DISEASE

Hindi Z; Shi N; Brahmania M; Pablo Arab J; Rajoriya N; Aithal GP; Allison ME; Hagstrom H; Likhitsup A; McCune A; Masson S; Parker R
Conference publication: JOURNAL OF HEPATOLOGY. 2021;75:S488

External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population

Astrom H; Ndegwa N; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2021;75:S251-S252

Life expectancy and risk of cardiovascular disease in non-alcoholic fatty liver disease: a population-based cohort study

Shang Y; Nasr P; Widman L; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2021;75:S557-S558

The prognosis is impaired in NAFLD patients with diabetes despite negative FIB4 <1.30

Boursier J; Ekstedt M; Gomez MR; Moreau C; Bonacci M; Cure S; Trylesinski A; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2021;75:S554

Indirect healthcare costs in biopsy-proven NAFLD is higher than in matched controls and independent of comorbidities

Gruneau L; Widman L; Henriksson M; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2021;75:S692-S693

Three-fold increased risk for death in Budd-Chiari syndrome compared to matched controls-population-based cohort study

Aberg F; Widman L; Rajani R; Hagstrom H
Preprint: SSRN ELECTRONIC JOURNAL. 2021

Pregnancy Outcomes in Women with Autoimmune Hepatitis – a Nationwide Population-Based Cohort Study with Histopathology

Sharma R; Simon TG; Stephansson O; Verna EC; Emond J; Söderling J; Roelstraete B; Hagström H; Ludvigsson JF
Conference publication: JOURNAL OF HEPATOLOGY. 2021;75:S269

Treatment of NAFLD with intermittent calorie restriction, low-carb high-fat diet or standard dietary advice-a randomized controlled trial

Holmer M; Lindqvist C; Petersson S; Moshtaghi-Svensson J; Tillander V; Brismar T; Hagstrom H; Stal P
Editorial comment: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2020;51(11):1204-1205

Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD?

Hagström H
Review: GASTROENTEROLOGY. 2020;158(6):1611-1625.e12

Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Taylor RS; Taylor RJ; Bayliss S; Hagström H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wai-Sun Wong V; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN
Conference publication: HEPATOLOGY. 2020;72:378A-379A

A SYSTEMATIC REVIEW OF COMPREHENSIVE MODELS OF CARE FOR NAFLD AND NASH

Lazarus JV; Mark HE; Cortez-Pinto H; Hagstrom H; Villota M; Wong V; Zelber-Sagi S; Romero-Gomez M; Schattenberg JM
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S166-S167

Europe's largest meta-analysis on the prevalence of non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and advanced fibrosis (F3-F4)

Petta S; Hagstrom H; Geier A; Ratziu V; Caballeria L; Exposito C; Hernandez R; Blokzijl H; De Knegt R; Ferrinho D; Ntalla I; Smith A; Ramroth H; Newsome PN
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S562

Treatment with sorafenib on hepatocellular carcinoma-10 years' experience in a nursing-led outpatient clinic

Grujcic G; Loqvist P; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S420

Macrophage markers do not add to the prediction of liver fibrosis by transient elastography in patients with non-alcoholic fatty liver disease

Kazankov K; Rosso C; Younes R; Hagstrom H; Moller HJ; Stal P; Bugianesi E; Gronbaek H
Conference publication: HEPATOLOGY. 2020;72:967

FIB-4 AND FIBROSCAN CAN IDENTIFY PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE WHO ARE AT RISK OF LIVER-RELATED EVENTS: RESULTS OF A LONGITUDINAL ANALYSIS WITH COMPARISON WITH LIVER BIOPSY

Boursier J; Hagstrom H; Ekstedt M; Moreau C; Bonacci M; Cures S; Trylesinski A; Romero-Gomez M
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S128-S129

Bariatric surgery is not associated with a reduction in risk of severe liver disease in comparison to standard obesity treatment in 3,922 subjects

Hagstrom H; Ekstedt M; Olbers T; Peltonen M; Carlsson L
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S541

Prognosis in persons with an HFE-mutation: population-based cohort study of 3,645 individuals

Hagstrom H; Ndegwa N; Ekstedt M; Posserud I; Rorsman F; Nyhlin N; Klintman D; Werner M; Marschall H-U; Askling J; Stal P
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S108

Liver disease progression and clinical outcomes in hepatic outcomes and survival fatty liver registry (HOTSURFR) study

Kutala B; Boursier J; Ekstedt M; Hagstrom H; Pais R; Bugianesi E; George J; Schattenberg JM; Anstee Q; Bedossa P; Ratziu V
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S63

Primary liver cancer in acute hepatic porphyria: a national cohort study

Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagstrom H; Sardh E; Wahlin S
Conference publication: GASTROENTEROLOGY. 2020;158(6):S1285-S1286

MORTALITY RISK IN BIOPSY-VERIFIED AUTOIMMUNE HEPATITIS: A NATIONWIDE POPULATION-BASED COHORT STUDY

Sharma R; Verna EC; Soderling J; Roelstraete B; Hagstrom H; Ludvigsson JF
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S178

Mortality in biopsy-proven alcohol-related liver disease: population-based cohort study of 3,453 individuals

Hagstrom H; Thiele M; Roelstraete B; Soderling J; Ludvigsson JF
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S371-S372

Long-term risk of HCC in persons with cirrhosis: national, population-based cohort study of 7,322 individuals

Bengtsson B; Widman L; Wahlin S; Stal P; Bjorkstrom N; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S70-S71

Repeated measures of FIB-4 improve prediction of severe liver disease: population-based cohort study of 40,729 individuals

Hagstrom H; Talback M; Andreasson A; Walldius G; Hammar N
Conference publication: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2020;35:35

Etiology and natural course of chronic pancreatitis

Dugic A; Berggren R; Aljic A; Waldthaler A; Panic N; Valente R; Pozzi-Mucelli R; Ghorbani P; Maisonneuve P; Hagstrom H; Lohr M; Vujasinovic M
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2019;17(12):2619-2620

Predictive Capacity for Mortality and Severe Liver Disease of the Relative Fat Mass Algorithm.

Andreasson A; Carlsson AC; Önnerhag K; Hagström H
Editorial comment: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2019;13(7):603-605

Is teenage heavy drinking more hazardous than we thought?

Hagström H; Andreasson A
Letter: HEPATOLOGY COMMUNICATIONS. 2019;3(6):848

Reply.

Hagström H; Williamson C; Marschall H-U
Meeting abstract: JOURNAL OF HEPATOLOGY. 2019;70(1):E817-E818

Transient elastography in normal pregnancies: A prospective cohort study

Ribeiro MS; Stal P; Hagstrom H; Ajne G
Conference publication: HEPATOLOGY. 2019;70:755A-756A

THE PREDICTED BENEFITS OF TREATMENTS FOR NONALCOHOLIC STEATOHEPATITIS ARE LIMITED IN PATIENTS WITHOUT CIRRHOSIS

Rowe I; Hagstrom H; Ekstedt M; Parker R
Conference publication: HEPATOLOGY. 2019;70:1093A

GOLEXANOLONE EXHIBITS LITTLE GENDER DIFFERENCE IN PHARMACOKINETICS AND IS WELL TOLERATED BY PATIENTS WITH CIRRHOSIS AT PLASMA LEVELS SHOWN TO MITIGATE THE CNS EFFECTS OF ALLOPREGNANOLONE.

Berglund JE; Rorsman F; Zupanets I; Partinen M; Jennum P; Lakner G; Wasling P; Hagstrom H; Kechagias S; Lamusuo S; Ocklind C; Arlander E; Backstrom T; Doverskog M; Johansson M; Mansson M; Samuelson P; Schalling M; Wennerholm A; Scharschmidt BF
Conference publication: JOURNAL OF HEPATOLOGY. 2019;70(1):E769

Prediction of incident severe liver disease in the general population using non-invasive scoring systems

Hagstrom H; Talback M; Andreasson A; Carlsson A; Walldius G; Hammar N
Editorial comment: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2018;48(9):1017-1018

Editorial: severe outcomes are rare in pregnancy with autoimmune hepatitis.

Hagstrom H; Ludvigsson JF
Letter: JOURNAL OF HEPATOLOGY. 2018;69(1):252-253

Reply to: "A measure of alcohol consumption in late adolescence associated with liver disease after 39 years of follow-up is insufficient to guide alcohol safe limits".

Hagström H; Hemmingsson T; Discacciati A; Andreasson A
Conference publication: JOURNAL OF HEPATOLOGY. 2018;68:S693-S694

Outcomes of pregnancy in women with cirrhosis - a national, population-based cohort study

Hagstrom H; Hoijer J; Marschall H-U; Williamson C; Heneghan M; Westbrook R; Ludvigsson JF; Stephansson O
Conference publication: JOURNAL OF HEPATOLOGY. 2018;68:S573-S574

A new score to predict presence of advanced fibrosis in NAFLD and comparison with established scoring systems

Hagstrom H; Nasr P; Ekstedt M; Hammar U; Hultcrantz R; Stal P; Kechagias S
Conference publication: HEPATOLOGY. 2018;68:970A-971A

High Body Mass Index in Young Adulthood and Future Risk of Severe Liver Disease: A National, Population-Based Cohort Study in 1.1 Million Women

Hagstrom H; Hoijer J; Andreasson A; Bottai M; Johansson K; Ludvigsson JF; Stephansson O
Conference publication: HEPATOLOGY. 2018;68:950A

Cardiovascular Risk Factors in Non-Alcoholic Fatty Liver Disease

Hagstrom H; Nasr P; Ekstedt M; Hammar U; Stal P; Hultcrantz RW; Kechagias S
Conference publication: HEPATOLOGY. 2018;68:993A-994A

Health Care Costs Associated with NAFLD - a Long-Term Follow up Study

Hagstrom H; Nasr P; Ekstedt M; Hammar U; Stal P; Hultcrantz RW; Kechagias S; Henriksson M
Conference publication: HEPATOLOGY. 2018;68:781A-782A

Type and Pattern of Alcohol Consumption in Adolescent Men and Risk of Severe Liver Disease Later in Life: A National, Population-Based Cohort Study

Hagstrom H; Discacciat AI; Hemmingsson T; Andreasson A
Conference publication: HEPATOLOGY. 2018;68:999A-1000A

A Lifestyle Intervention in Patients with Type 2 Diabetes Aimed to Improve Glycemic Control Also Reduces Hepatic Stiffness

Bjorkstrom K; Stal P; Holmer M; Bengtsson B; Staaf A; Hoffstedt J; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2018;68:S823

Risk factors for development of severe liver disease in more than 400 000 patients with type 2 diabetes: A population-based cohort study

Bjorkstrom K; Franzen S; Eliasson B; Miftaraj M; Gudbjornsdottir S; Trolle-Lagerros Y; Svensson A-M; Hagstrom H
Conference publication: HEPATOLOGY. 2018;68:59A-60A

Lipophilic Statins and Risk of Hepatocellular Carcinoma and Mortality: A Prospective, Nationwide Population with Chronic Viral Hepatitis

Simon TG; Duberg A-S; Aleman S; Hagstrom H; Chung RT; Ludvigsson JF
Review: HEPATOLOGY. 2017;65(5):1557-1565

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.

Dulai PS; Singh S; Patel J; Soni M; Prokop LJ; Younossi Z; Sebastiani G; Ekstedt M; Hagstrom H; Nasr P; Stal P; Wong VW-S; Kechagias S; Hultcrantz R; Loomba R
Review: CURRENT HEPATITIS REPORTS. 2017;16(2):152-157

Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?

Hagström H
Conference publication: JOURNAL OF HEPATOLOGY. 2017;66(1):S71

High BMI in late adolescence predicts future severe liver disease: a national, population-based cohort study in 1.2 million men

Hagstroem H; Tynelius P; Rasmussen F
Conference publication: JOURNAL OF HEPATOLOGY. 2017;66(1):S421-S422

NAFLD as an indication for liver transplantation in the Nordic countries - a cohort study during 1982-2015

Holmer M; Melum E; Isoniemi H; Ericzon B-G; Castedal M; Nordin A; Schultz NA; Rasmussen A; Line P-D; Stal P; Bennet W; Hagstrom H
Letter: HEPATOLOGY. 2016;64(1):310-311

Reply.

Ekstedt M; Hagström H; Nasr P; Fredrikson M; Stal P; Kechagias S; Hultcrantz R
Thesis / dissertation: 2016

The importance of fat and alcohol for progression and prognosis in chronic liver disease

Hagström, Hannes
Review: LAKARTIDNINGEN. 2016;113:DL6L

[Infections common in acute and chronic liver disease].

Hagström H; Rorsman F
Conference publication: JOURNAL OF HEPATOLOGY. 2016;64:S135

SAF SCORE AS A MARKER FOR MORTALITY IN NAFLD AFTER UP TO 41 YEARS OF FOLLOW-UP

Hagstrom H; Ekstedt PNM; Bedossa P; Stal P; Kechagias S; Hultcrantz R
Conference publication: HEPATOLOGY. 2016;64:531A

Fibrosis progression and mortality in non-alcoholic fatty liver disease

Elfwen O; Stal P; Hultcrantz RW; Hagstrom H
Conference publication: HEPATOLOGY. 2016;64:18A-19A

Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease

Hagstrom H; Nasr P; Ekstedt M; Kechagias S; Onnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall H-U; Stal P; Hultcrantz RW
Conference publication: HEPATOLOGY. 2016;64:552A-553A

Risk of Mortality by Fibrosis Stage in NAFLD: A Systematic Review and Meta-Analysis

Patel JR; Dulai PS; Younossi ZM; Sebastiani G; Ekstedt M; Hagstrom H; Nasr P; Stal P; Kechagias S; Hultcrantz RW; Singh S; Loomba R
Conference publication: HEPATOLOGY. 2016;64:531A

Risk factors for type 2 diabetes mellitus development in non-alcoholic fatty liver disease after up to 41 years follow-up

Bjorkstrom NK; Stal P; Hultcrantz RW; Hagstrom H
Conference publication: HEPATOLOGY. 2015;62:368A

Tacrolimus or Mycophenylate mofetil as a second-line therapeutic options in patients with Autoimmune Hepatitis: An international multicentre observational study

Efe C; Hagstrom H; Bhanji RA; Mueller NF; Wang Q; Purnak T; Muratori L; Werner M; Marschall H-U; Muratori P; Gunsar F; Klintman D; Pares A; Heurgue-Berlot A; Schiano TD; Ma X; Montano-Loza AJ; Berg T; Ozaslan E; Yoshida EM; Wahlin S
Conference publication: HEPATOLOGY. 2015;62:289A

Overweight in late adolescence is associated with decompensated liver disease later in life after 39 years of follow-up

Hagstrom H; Stal P; Hultcrantz RW; Hemmingsson T; Andreasson A
Review: PLOS MEDICINE. 2014;11(7):e1001680

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.

Musso G; Gambino R; Tabibian JH; Ekstedt M; Kechagias S; Hamaguchi M; Hultcrantz R; Hagström H; Yoon SK; Charatcharoenwitthaya P; George J; Barrera F; Hafliðadóttir S; Björnsson ES; Armstrong MJ; Hopkins LJ; Gao X; Francque S; Verrijken A; Yilmaz Y; Lindor KD; Charlton M; Haring R; Lerch MM; Rettig R; Völzke H; Ryu S; Li G; Wong LL; Machado M; Cortez-Pinto H; Yasui K; Cassader M
Conference publication: HEPATOLOGY. 2014;60:604A

Adverse outcomes of pregnancy in mothers with NAFLD and their offspring

Hagstrom H; Ludvigsson JF; Ekbom A; Hultcrantz RW; Stephansson O; Stokkeland K
Conference publication: HEPATOLOGY. 2013;58(6):1380A-1381A

Fibrosis stage, but not NAS, is predictive for disease-specific mortality in NAFLD after 33 years of follow-up

Ekstedt M; Hagstrom H; Nasr PS; Fredrikson M; Stal P; Kechagias S; Hultcrantz RW
Visa fler

Anställningar

Adjungerad Professor, Medicin, Huddinge, Karolinska Institutet, 2024-2028
Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2023-2026

Examina och utbildning

Docent, gastroenterologi och hepatologi, Karolinska Institutet, 2019
Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2016
Läkarexamen, Karolinska Institutet, 2007

Handledare

Bonnie Bengtsson, Liver cirrhosis - epidemiology, prognosis, and cancer
Karl Björkström, From fatty liver to end-stage liver disease through type 2 diabetes, https://www.avhandlingar.se/avhandling/cf512e5847/

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Handledare

Nyheter från KI

Kalenderhändelser från KI